Latest Headlines

  1. Lucent Diagnostics And Life Line Screening Partner To Bring Advanced Blood-Based Diagnostics To Communities Nationwide 3/2/2026

    Lucent Diagnostics, a brand of Quanterix Corporation today announced a partnership with Life Line Screening (LLS), a national organization focused on identifying asymptomatic risks for chronic conditions in community health settings.

  2. Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media To Help Detect Candida Infections Faster*, Including Drug-Resistant Candida Auris 3/2/2026

    Thermo Fisher Scientific, the world leader in serving science, today announced the launch of Thermo Scientific Brilliance Candida 2 Agar and Spectra Candida Agar**, new color-based (chromogenic) culture media to help laboratories quickly detect and differentiate clinically important Candida species — including Candida auris, a growing global antimicrobial resistance (AMR) threat1.

  3. Quest Diagnostics Introduces AI Companion To Help Patients Understand And Act On Lab Test Results 3/2/2026

    Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced Quest AI Companion, a new AI-powered chat feature that helps individuals analyze, understand and act on their Quest laboratory test results with their healthcare provider.

  4. Acupath Laboratories, Inc. Partners With Azer Scientific To Install The First AzerView Digital Pathology Scanner In The United States 2/27/2026

    Three pathology and healthcare technology leaders today announced a partnership that has resulted in the installation of the first LH510 Digital Pathology scanner in the United States, marking a significant milestone in the advancement of digital pathology and diagnostic innovation.

  5. Illumina Whole-Genome Sequencing Technology To Accelerate Rare Disease Testing In Florida 2/27/2026

    Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina's CLIA-certified laboratory, is providing clinical sequencing and interpretation services to the new Diagnostic Lab at Florida Institute for Pediatric Rare Diseases (IPRD) at Florida State University (FSU) College of Medicine, further driving innovation in diagnostics and treatments for rare diseases.

  6. ARUP Creates Innovation Central Laboratory To Accelerate Diagnostic Innovation For Biotechnology And Pharmaceutical Partners 2/26/2026

    ARUP Laboratories, a leader in diagnostic medicine and the largest nonprofit reference laboratory in the U.S., today announced the launch of a new Innovation Central Laboratory to facilitate collaboration with pharmaceutical, biotechnology, and other industry partners.

  7. Thermo Fisher Scientific Introduces New Laboratory Developed Test To Help Transplant Patients Receive The Right Dose Of Critical Anti-Rejection Medication Sooner 2/26/2026

    Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TacroType Pharmacogenetic Test, a new laboratory developed test designed to help inform clinicians on dosing tacrolimus, a commonly prescribed immunosuppressive drug for transplant recipients to lower the risk of rejection.

  8. 20/20 BioLabs Launches OneTest For Longevity Blood Test And Chronic Disease Risk Assessment And Management Solution Built With IBM AI Capabilities 2/25/2026

    20/20 BioLabs (Nasdaq: AIDX), an early market leader in cutting-edge, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, announces the launch and commercial availability of its OneTest for Longevity solution.

  9. Ultima Genomics And Hamilton Partner To Automate Sample Preparation And Amplification Workflows For The Ultima Family Of Sequencing Systems To Enable Improved Lab Operations And Drive Sequencing At Scale 2/25/2026

    Ultima Genomics, a developer of ultra-high-throughput sequencing systems, together with Hamilton (Hamilton Company and Hamilton Bonaduz AG), a global leader in precision laboratory automation, today announced a partnership to automate Ultima's latest sample preparation and amplification technology across Hamilton's Microlab® STAR™ liquid handling platform.

  10. Illumina Launches TruPath Genome, Setting A New Standard In Genomic Insight 2/24/2026

    Illumina, Inc. (NASDAQ: ILMN) today announced the launch of TruPath™ Genome, setting a new standard for high-quality, comprehensive whole genome insights for genetic disease.